About this episode

Otello Stampacchia discusses the challenges and potential reforms needed in Europe's biotech investment landscape.

Otello Stampacchia, founder and managing director of Omega Funds, on attempting to reform Europe's biotech investment climate.

More episodes of The Long Run with Luke Timmerman

• Ep200: Richard Pops Reflects on a 35-Year Career in Biotech · May 5, 2026 · 1h 14m
• Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery · April 7, 2026 · 1h 17m
• Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature · March 31, 2026 · 1h 17m
• Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases · March 3, 2026 · 1h 6m
• Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery · February 17, 2026 · 1h 9m
• Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines · January 22, 2026 · 1h 5m

Explore listener stats, chart rankings, contacts and more on the The Long Run with Luke Timmerman podcast page.